Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin G McCabe

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Pediatric Blood & Cancer|July 6, 2021
Oral etoposide as a single agent in childhood and young adult cancer in England: Still a poorly evaluated palliative treatmentJess Fraser, Lorna Wills, Fahmina Fardus-Reid, et al.
BMJ Open|April 22, 2019
Description of the BRIGHTLIGHT cohort: the evaluation of teenage and young adult cancer services in EnglandRachel M Taylor, Lorna A Fern, Julie Barber, et al.
BMC Cancer|January 24, 2024
Protocol for the development of a Core Outcome Set (COS) for Adolescents and Young Adults (AYAs) with cancerOlga Husson, Silvie H M Janssen, Bryce B Reeve, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 28, 2024
CT- and MR-based image-based data mining are consistent in the brainLydia J Wilson, Angela Davey, Eliana Vasquez Osorio, et al.
Journal of Adolescent and Young Adult Oncology|July 18, 2017
Cancer-Related Fatigue in Adolescents and Young Adults After Cancer Treatment: Persistent and Poorly ManagedAnna Spathis, Helen Hatcher, Sara Booth, et al.
Neuro-Oncology Practice|April 26, 2018
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluationKatrina A Morris, John F Golding, Patrick R Axon, et al.
BMJ Open|November 25, 2025
Educational outcomes for children and young people with cancer: study protocol for a population-based cohort study using linked education and hospital data from EnglandSelina Nath, Tony Stone, Joseph Lam, et al.
The Lancet. Oncology|December 25, 2025
Development of a core outcome set for adolescents and young adults with cancerAnne-Sophie Darlington, Kirsty Way, Nicole Collaço, et al.
Cancers|December 11, 2025
Does Joint Care Impact Teenage and Young Adult's Patient-Reported Outcomes After a Cancer Diagnosis? Results from BRIGHTLIGHT_2021Lorna A Fern, Elysse Bautista-Gonzalez, Julie A Barber, et al.
Journal of Neuro-Oncology|November 1, 2016
Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohortKatrina A Morris, John F Golding, Claire Blesing, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Pediatric Blood & Cancer|July 6, 2021
Oral etoposide as a single agent in childhood and young adult cancer in England: Still a poorly evaluated palliative treatmentJess Fraser, Lorna Wills, Fahmina Fardus-Reid, et al.
BMJ Open|April 22, 2019
Description of the BRIGHTLIGHT cohort: the evaluation of teenage and young adult cancer services in EnglandRachel M Taylor, Lorna A Fern, Julie Barber, et al.
BMC Cancer|January 24, 2024
Protocol for the development of a Core Outcome Set (COS) for Adolescents and Young Adults (AYAs) with cancerOlga Husson, Silvie H M Janssen, Bryce B Reeve, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 28, 2024
CT- and MR-based image-based data mining are consistent in the brainLydia J Wilson, Angela Davey, Eliana Vasquez Osorio, et al.
Journal of Adolescent and Young Adult Oncology|July 18, 2017
Cancer-Related Fatigue in Adolescents and Young Adults After Cancer Treatment: Persistent and Poorly ManagedAnna Spathis, Helen Hatcher, Sara Booth, et al.
Neuro-Oncology Practice|April 26, 2018
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluationKatrina A Morris, John F Golding, Patrick R Axon, et al.
BMJ Open|November 25, 2025
Educational outcomes for children and young people with cancer: study protocol for a population-based cohort study using linked education and hospital data from EnglandSelina Nath, Tony Stone, Joseph Lam, et al.
The Lancet. Oncology|December 25, 2025
Development of a core outcome set for adolescents and young adults with cancerAnne-Sophie Darlington, Kirsty Way, Nicole Collaço, et al.
Cancers|December 11, 2025
Does Joint Care Impact Teenage and Young Adult's Patient-Reported Outcomes After a Cancer Diagnosis? Results from BRIGHTLIGHT_2021Lorna A Fern, Elysse Bautista-Gonzalez, Julie A Barber, et al.
Journal of Neuro-Oncology|November 1, 2016
Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohortKatrina A Morris, John F Golding, Claire Blesing, et al.
Pageof 8